Literature DB >> 6191341

Monoclonal antibodies against the G1 and nucleocapsid proteins of LaCrosse and Tahyna viruses.

F Gonzalez-Scarano, R E Shope, C H Calisher, N Nathanson.   

Abstract

Monoclonal antibodies against the Gl (glycoprotein) and Nc (nucleocapsid) proteins of LaCrosse (LAC) and Tahyna (TAH) viruses were generated using a standard protocol. Monoclonal antibodies against Gl were either neutralizing or non-neutralizing, and there was close concordance between inhibition of hemagglutination and neutralizing activities. The LAC virus neutralizing antibodies could be further subdivided into strain-specific and cross-reactive groups on the basis of both neutralization and inhibition of hemagglutination. These data support the concept of a glycoprotein molecule with three antigenic sites, two involved in neutralization and hemagglutination, and an additional site with no biological function as yet defined. Preliminary information from LAC virus variants selected with these monoclonal antibodies agrees with this interpretation. Anti Nc antibodies were all cross-reactive in an ELISA assay. Patterns of monoclonal cross-reactivity against California serogroup viruses are compared with the currently accepted antigenic relationships.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191341

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  3 in total

1.  Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.

Authors:  A Pekosz; C Griot; K Stillmock; N Nathanson; F Gonzalez-Scarano
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

2.  Prevalence and protein specificity of human antibodies to Inkoo virus infection.

Authors:  Niina Putkuri; Antti Vaheri; Olli Vapalahti
Journal:  Clin Vaccine Immunol       Date:  2007-10-17

3.  Validation of a commercially available indirect ELISA using a nucleocapside recombinant protein for detection of Schmallenberg virus antibodies.

Authors:  Emmanuel Bréard; Estelle Lara; Loïc Comtet; Cyril Viarouge; Virginie Doceul; Alexandra Desprat; Damien Vitour; Nathalie Pozzi; Ann Brigitte Cay; Nick De Regge; Philippe Pourquier; Horst Schirrmeier; Bernd Hoffmann; Martin Beer; Corinne Sailleau; Stéphan Zientara
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.